The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of circulating tumor DNA in the phase 2 BTCRC LUN 16-081 trial of consolidation nivolumab with or without ipilimumab after chemoradiation in stage III non–small cell lung cancer.
 
Soyeong Jun
No Relationships to Disclose
 
Nikhil Shukla
Employment - Loxo
Patents, Royalties, Other Intellectual Property - Combination of SapC-DOPS and AS1411 for the treatment of glioblastoma multiforme (Inst)
 
Greg Andrew Durm
Honoraria - AstraZeneca; Curio Science
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
 
Angela B. Hui
No Relationships to Disclose
 
Sha Cao
No Relationships to Disclose
 
Christian Kunder
Employment - Genentech (I)
Stock and Other Ownership Interests - Genentech (I)
Consulting or Advisory Role - Natera
 
Ash A. Alizadeh
Leadership - Lymphoma Research Foundation
Stock and Other Ownership Interests - Capp Medical; CiberMed; Forty Seven
Honoraria - Janssen Oncology; Roche
Consulting or Advisory Role - Celgene; CiberMed; Foresight Diagnostics; Gilead Sciences; Roche/Genentech
Research Funding - Celgene
Patents, Royalties, Other Intellectual Property - Patent filings on ctDNA detection, assigned to Stanford University. (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Roche
 
Nasser H. Hanna
Honoraria - UpToDate
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck KGaA (Inst)
 
Maximilian Diehn
Leadership - Foresight Diagnostics
Stock and Other Ownership Interests - CiberMed; Foresight Diagnostics
Consulting or Advisory Role - AstraZeneca; BioNTech; Boehringer Ingelheim; Genentech; Gritstone Bio; Illumina; Novartis; Reflexion Medical; Roche
Research Funding - AstraZeneca (Inst); Genentech (Inst); Illumina (Inst); Varian Medical Systems (Inst)
Patents, Royalties, Other Intellectual Property - Patent filings on ctDNA detection assigned to Stanford University (Inst); Patent filings on tumor treatment resistance mechanisms assigned to Stanford University (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche; Varian Medical Systems